CD8A and osteosarcoma: In addition, the high presence of tumor-infiltrating lymphocytes in osteosarcoma TME and the correlation between CD8 T cells and higher survival rate has led to the hypothesis that ICI therapy could be effective in osteosarcoma [67–69].